Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lance D Dworkin

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 6, 2017
Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis PatientsSusie L Hu, Priyanka Joshi, Mark Kaplan, et al.
Kidney International|July 11, 2021
The ketone body β-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insultsYudong Fang, Bohan Chen, Athena Y Gong, et al.
Journal of the American Society of Nephrology : JASN|November 29, 2022
Negative Modulation of B Cell Activation by Melanocortin 1 Receptor Signaling Protects against Membranous NephropathyBohan Chen, Xuejing Guan, William T Gunning, et al.
American Journal of Translational Research|April 10, 2020
Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes <i>via</i> a GSK3β dependent mechanismXianhui Liang, Bohan Chen, Pei Wang, et al.
Kidney International|January 14, 2004
Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injuryLance D Dworkin, Rujun Gong, Evelyn Tolbert, et al.
Clinical Science (London, England : 1979)|March 14, 2020
Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signalingYingjin Qiao, Pei Wang, Mingyang Chang, et al.
Kidney Diseases (Basel, Switzerland)|December 22, 2018
Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future PerspectivesEman Shaban, George Bayliss, Deepak K Malhotra, et al.
Kidney International|January 25, 2025
Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathiesBohan Chen, Mengxuan Chen, Mingyang Chang, et al.
American Journal of Nephrology|September 23, 2016
Medical Neighborhood Model for the Care of Chronic Kidney Disease PatientsZoe G Smith, Lynn McNicoll, Timothy L Clark, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2012
Genetic or pharmacologic blockade of EGFR inhibits renal fibrosisNa Liu, Jian-Kan Guo, Maoyin Pang, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 6, 2017
Rapid Change in Residual Renal Function Decline Is Associated with Lower Survival and Worse Residual Renal Function Preservation in Peritoneal Dialysis PatientsSusie L Hu, Priyanka Joshi, Mark Kaplan, et al.
Kidney International|July 11, 2021
The ketone body β-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insultsYudong Fang, Bohan Chen, Athena Y Gong, et al.
Journal of the American Society of Nephrology : JASN|November 29, 2022
Negative Modulation of B Cell Activation by Melanocortin 1 Receptor Signaling Protects against Membranous NephropathyBohan Chen, Xuejing Guan, William T Gunning, et al.
American Journal of Translational Research|April 10, 2020
Triptolide potentiates the cytoskeleton-stabilizing activity of cyclosporine A in glomerular podocytes <i>via</i> a GSK3β dependent mechanismXianhui Liang, Bohan Chen, Pei Wang, et al.
Kidney International|January 14, 2004
Hepatocyte growth factor ameliorates progression of interstitial fibrosis in rats with established renal injuryLance D Dworkin, Rujun Gong, Evelyn Tolbert, et al.
Clinical Science (London, England : 1979)|March 14, 2020
Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signalingYingjin Qiao, Pei Wang, Mingyang Chang, et al.
Kidney Diseases (Basel, Switzerland)|December 22, 2018
Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future PerspectivesEman Shaban, George Bayliss, Deepak K Malhotra, et al.
Kidney International|January 25, 2025
Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathiesBohan Chen, Mengxuan Chen, Mingyang Chang, et al.
American Journal of Nephrology|September 23, 2016
Medical Neighborhood Model for the Care of Chronic Kidney Disease PatientsZoe G Smith, Lynn McNicoll, Timothy L Clark, et al.
Journal of the American Society of Nephrology : JASN|February 25, 2012
Genetic or pharmacologic blockade of EGFR inhibits renal fibrosisNa Liu, Jian-Kan Guo, Maoyin Pang, et al.
Pageof 8